Melanoma study pulled before start: local attack on resistant tumors never tested
Disease control
Terminated
This study planned to test whether adding surgery, radiation, or electrochemotherapy could help control melanoma spots that did not shrink with the targeted drug combo encorafenib + binimetinib. It was designed for adults with BRAF-mutated melanoma who had been on the drugs for a…
Phase: PHASE4 • Sponsor: SRH Wald-Klinikum Gera GmbH • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC